Correlation Between Crinetics Pharmaceuticals and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Mineralys Therapeutics,.
Diversification Opportunities for Crinetics Pharmaceuticals and Mineralys Therapeutics,
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Crinetics and Mineralys is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Mineralys Therapeutics,
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Crinetics Pharmaceuticals is 1.13 times less risky than Mineralys Therapeutics,. The stock trades about -0.2 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 1,255 in Mineralys Therapeutics, Common on November 4, 2024 and sell it today you would lose (225.00) from holding Mineralys Therapeutics, Common or give up 17.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Mineralys Therapeutics, |
Crinetics Pharmaceuticals and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Mineralys Therapeutics,
The main advantage of trading using opposite Crinetics Pharmaceuticals and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |